Human cathelicidin antimicrobial peptide that disrupts bacterial membranes, modulates TLR signaling, and promotes wound healing.
For athletes, the primary value of LL-37 lies in its ability to antimicrobial action, wound healing, and innate immune activation.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.
Variable — onset typically within 2–8 weeks depending on protocol and individual response.
Individual response varies based on injury severity, training load, and baseline health markers.
Pro-inflammatory at high doses. Careful dosing required.
Always verify current WADA status with your sport's governing body before use in competition.
https://pubmed.ncbi.nlm.nih.gov/12540857/
Start a LL-37 Protocol
Hatter Labs provides physician-supervised performance protocols with GMP-certified LL-37 and comprehensive biomarker monitoring.
Get ProtocolCompare & Stack
Start Your Performance Protocol for LL-37
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised